Blood Pressure
Conditions
Brief summary
To determine accuracy of nightly non occlusive blood pressure measurements by the non-occlusive CSEM Pulse Watch compared to a gold standard oscillometric device Spacelabs OnTrak Ambulatory Blood Pressure monitor, Spacelabs Healthcare, Washington, USA) internationally validated for the 24h ABPM in Patients.
Detailed description
Elevated Blood Pressure (BP) is a chronic medical condition with a prevalence of about 45% in the middle-aged population. The particular interest of this project is given to the diagnosis and treatment of so-called nocturnal hypertension. Unfortunately, current monitoring practice relies on the use of occlusive pneumatic cuffs inflated around the arm to assess BP. Based on oscillometric technique, occlusive cuffs perform intermittent BP measurements every 20 minutes, thus providing only a limited view of the BP regulation landscape. In addition, oscillometric measurement performs a full occlusion of the measured arm inducing awakening reactions, and leading to non-representative overestimated BP values. The non-occlusive measurement of BP is thus an unsolved problem of modern medicine. The aim of the NAMBP (Night Ambulatory Monitoring of Blood Pressure) project is to develop, implement and test in clinical trials a first-ever non-occlusive BP sensor to be used during sleep. A novel technology for the non-occlusive measurement of BP from photoplethysmographic (optical) signals, known as Pulse Wave Analysis (PWA), has been investigated for the past decade by the Centre Suisse d'Electronique et de Microtechnique (CSEM, Neuchâtel, Switzerland). The herein proposed system - the CSEM Pulse Watch - consists in a single sensor (watch-like device) attached at the wrist that measures photoplethysmographic waveforms induced by the pulsatility of the skin arteries of the wrist. These waveforms are then post-processed via PWA: The system will detect features in the measured waveforms that correlate, through the phenomenon of wave reflections, to the underlying BP of the patient.
Interventions
DEVICECSEM Pulse Watch
Comparison of CSEM Pulse Watch with a gold standard oscillometric device Spacelabs OnTrak Ambulatory Blood Pressure monitor.
Sponsors
CSEM Centre Suisse d'Electronique et de Microtechnique SA - Recherche et Developpement
Insel Gruppe AG, University Hospital Bern
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE
Intervention model description
Prospective, method-comparison, proof of concept, single centre study
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* Patients \> 18y * Good understanding of written and oral German * Signed informed consent * Scheduled for 24h blood pressure exam
Exclusion criteria
* Patients with unhealthy mental state * Patients with an active implantable medical device (AIMD) * Arteriopathy of the upper limbs with/without stenosis * Severe congestive heart failure (LV-EF ≤25%) * Sever aortic-valve stenosis mean gradient \>40mmHg, valve area \<1cm2) * Congenital heart disease including aortic isthmus stenosis * Untreated heart rhythm disorders, heart rate at rest \> 120/bpm * Severe untreated arterial hypertension (BPsyst \> 180mmHg, BPdiast \> 100mmHg) * Atrial fibrillation * Instable angina pectoris * Malcompliance concerning medication intake * Active alcohol or drug abuse * Pregnancy or lactation (women of childbearing age will be asked to performed urinary pregnancy test before the screening phase)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Assessment of the accuracy | Day 0 for 24 hours | Continuous blood pressure measurement of the novel device will be compared to measurements assessed by a standard 24h blood pressure monitor at normal out of hospital conditions during night periods. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Assessment of the acceptability | Day 1 | Acceptability of the novel blood pressure device in patients when used during 24 hours will be assessed by means of a questionnaire filled in by patients at day 1. The scale title is: Fragebogen. The minimum value is -1 and the maximum value is 10. The higher score means worse outcome. |
Countries
Switzerland
Outcome results
None listed